Matches in Wikidata for { <http://www.wikidata.org/entity/Q81195635> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q81195635 description "article scientifique (publié 2009)" @default.
- Q81195635 description "artikull shkencor i botuar më 01 janar 2009" @default.
- Q81195635 description "artículu científicu espublizáu en xineru de 2009" @default.
- Q81195635 description "im Januar 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81195635 description "scientific article published on 01 January 2009" @default.
- Q81195635 description "wetenschappelijk artikel" @default.
- Q81195635 description "наукова стаття, опублікована в січні 2009" @default.
- Q81195635 description "գիտական հոդված հրատարակված 2009 թվականի հունվարի 1-ին" @default.
- Q81195635 name "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 name "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 name "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 type Item @default.
- Q81195635 label "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 label "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 label "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 prefLabel "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 prefLabel "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 prefLabel "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 P1433 Q81195635-6FF98267-C6D8-4137-933F-2E6C5621B5DA @default.
- Q81195635 P1476 Q81195635-1BB9223B-CF5B-476A-926E-756129E430A9 @default.
- Q81195635 P2093 Q81195635-093820D8-2209-4EC3-B1EC-8047CB858C2C @default.
- Q81195635 P2093 Q81195635-0F91E91C-181B-406E-88A8-971CD7C2BF68 @default.
- Q81195635 P2093 Q81195635-236AEEDD-383B-453F-9709-9BE479120365 @default.
- Q81195635 P2093 Q81195635-25B20555-5256-4ACD-9023-EA8BD0209FE0 @default.
- Q81195635 P2093 Q81195635-270F4C2C-DCED-46B4-A1C2-2F881F962085 @default.
- Q81195635 P2093 Q81195635-897C368F-A512-42F3-B3B1-DC4368C14953 @default.
- Q81195635 P2093 Q81195635-96C6FA88-3423-448B-8F42-25B3AA8544FC @default.
- Q81195635 P2093 Q81195635-D6A49A19-9FFE-4451-B854-433C5453724C @default.
- Q81195635 P304 Q81195635-8DDE2346-69D7-47B8-81E7-7C1609C2CD4C @default.
- Q81195635 P31 Q81195635-C770EF9B-1054-4E82-AC8A-2A8C6B8DD0E6 @default.
- Q81195635 P356 Q81195635-6A57D4BC-47C5-447F-B493-FFC8DBCD5EF0 @default.
- Q81195635 P407 Q81195635-5C0CFFA7-BCE1-4FD2-9063-BFEDB49B9512 @default.
- Q81195635 P433 Q81195635-526DF26B-A0B6-46E6-9EF2-97F5FD1FEB4D @default.
- Q81195635 P478 Q81195635-37674386-94D5-45E1-A414-1A3CC032AE23 @default.
- Q81195635 P577 Q81195635-E2D90C40-1AFD-4D6A-A065-8243FB197AA1 @default.
- Q81195635 P698 Q81195635-663D9A8F-AD7C-4DC8-84D6-DBB19A39A0EB @default.
- Q81195635 P921 Q81195635-59E8751C-9124-4019-90D6-8C23109D85D6 @default.
- Q81195635 P356 JPS.21425 @default.
- Q81195635 P698 18449936 @default.
- Q81195635 P1433 Q3186933 @default.
- Q81195635 P1476 "Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats" @default.
- Q81195635 P2093 "David R Anderson" @default.
- Q81195635 P2093 "J Scott Daniels" @default.
- Q81195635 P2093 "Jon G Selbo" @default.
- Q81195635 P2093 "Lesley A Albin" @default.
- Q81195635 P2093 "Po-Chang Chiang" @default.
- Q81195635 P2093 "Robert J Mourey" @default.
- Q81195635 P2093 "Sarah A South" @default.
- Q81195635 P2093 "Steve P Wene" @default.
- Q81195635 P304 "248-256" @default.
- Q81195635 P31 Q13442814 @default.
- Q81195635 P356 "10.1002/JPS.21425" @default.
- Q81195635 P407 Q1860 @default.
- Q81195635 P433 "1" @default.
- Q81195635 P478 "98" @default.
- Q81195635 P577 "2009-01-01T00:00:00Z" @default.
- Q81195635 P698 "18449936" @default.
- Q81195635 P921 Q461809 @default.